Show simple item record

Can our choice of contrast media impact renal and cardiovascular outcomes?

dc.contributor.authorPrasad, Anand
dc.contributor.authorGurm, Hitinder S.
dc.date.accessioned2016-04-05T19:46:16Z
dc.date.available2017-05-02T15:09:14Zen
dc.date.issued2016-03
dc.identifier.citationPrasad, Anand; Gurm, Hitinder S. (2016). "Can our choice of contrast media impact renal and cardiovascular outcomes?." Catheterization and Cardiovascular Interventions 87(4): 710-711.
dc.identifier.issn1522-1946
dc.identifier.issn1522-726X
dc.identifier.urihttps://hdl.handle.net/2027.42/117550
dc.publisherWiley Periodicals, Inc.
dc.titleCan our choice of contrast media impact renal and cardiovascular outcomes?
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/117550/1/ccd26483.pdf
dc.identifier.doi10.1002/ccd.26483
dc.identifier.sourceCatheterization and Cardiovascular Interventions
dc.identifier.citedreferenceGiustino G, Baber U, Mastoris I, Vlachojannis GJ, Yu J, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Nikolsky E, et al. One‐year results of the ICON (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study. Catheter Cardiovasc Interv 2016; 87: 703 – 709.
dc.identifier.citedreferenceMehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, et al. Ionic low‐osmolar versus nonionic iso‐osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: The ICON (Ionic versus non‐ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv 2009; 2: 415 – 421.
dc.identifier.citedreferenceBertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a nonionic, iso‐osmolar contrast medium (iodixanol) versus an ionic, low‐osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double‐blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators. Circulation 2000; 101: 131 – 136.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.